
Assessment of lamivudine, zidovudine, lopinavir, and ritonavir plasma levels in HIV-positive pregnant women
Author(s) -
Jessica HernándezPineda,
Helgi Jung–Cook,
Norah L. KatendeKyenda,
Norma Galindo-Sevilla,
Mauricio Domínguez-Castro,
José Romo-Yáñez,
Alicia Ramírez-Ramírez,
Claudine Irles,
Ricardo Figueroa-Damián
Publication year - 2020
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000020487
Subject(s) - lopinavir , lamivudine , zidovudine , ritonavir , medicine , protein precipitation , chromatography , therapeutic drug monitoring , formic acid , selected reaction monitoring , pyrimethamine , virology , tandem mass spectrometry , viral load , pharmacokinetics , mass spectrometry , pharmacology , human immunodeficiency virus (hiv) , virus , chemistry , viral disease , antiretroviral therapy , immunology , hepatitis b virus , malaria , plasmodium falciparum